Yao Ma and Lian-Sheng Wang
According to World Health Organization (WHO), ischemic heart disease is the highest cause of death in the world. As current guidelines recommend, Dual-Antiplatelet Therapy (DAPT) of aspirin and P2Y12 receptor inhibitor should be used at least 1 year in Acute Coronary Syndrome (ACS) patients with or without Percutaneous Coronary Intervention (PCI). We here present a complex PCI case who had complicated with atrial fibrillation (AF) after more than 1 year’s DAPT. Then, he took new oral anticoagulants (NOAC) only. Unfortunately, we found total thrombotic occlusion in his right coronary artery (RCA) stents. Finally, he was accepted coronary artery bypass grafting surgery (CABG).
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 